These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 11955864)

  • 1. Late-onset primary LVH HCM versus cardiac fabry variant.
    Frustaci A; Pieroni M; Chimenti C
    J Am Coll Cardiol; 2002 Apr; 39(8):1405-6; author reply 1406. PubMed ID: 11955864
    [No Abstract]   [Full Text] [Related]  

  • 2. Systolic myocardial mechanics in patients with Anderson-Fabry disease with and without left ventricular hypertrophy and in comparison to nonobstructive hypertrophic cardiomyopathy.
    Gruner C; Verocai F; Carasso S; Vannan MA; Jamorski M; Clarke JT; Care M; Iwanochko RM; Rakowski H
    Echocardiography; 2012 Aug; 29(7):810-7. PubMed ID: 22497597
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of left ventricular hypertrophy in adults in hypertrophic cardiomyopathy caused by cardiac myosin-binding protein C gene mutations.
    Maron BJ; Niimura H; Casey SA; Soper MK; Wright GB; Seidman JG; Seidman CE
    J Am Coll Cardiol; 2001 Aug; 38(2):315-21. PubMed ID: 11499718
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of base-to-apex circumferential strain gradient: A specific pattern of Fabry cardiomyopathy?
    Labombarda F; Saloux E; Milesi G; Bienvenu B
    Echocardiography; 2017 Apr; 34(4):504-510. PubMed ID: 28256008
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Comparison of left atrial size and function in hypertrophic cardiomyopathy and in Fabry disease with left ventricular hypertrophy.
    Saccheri MC; Cianciulli TF; Challapa Licidio W; Lax JA; Beck MA; Morita LA; Gagliardi JA;
    Echocardiography; 2018 May; 35(5):643-650. PubMed ID: 29457264
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A novel mutation in the cardiac myosin-binding protein C gene is responsible for hypertrophic cardiomyopathy with severe ventricular hypertrophy and sudden death.
    Konno T; Shimizu M; Ino H; Fujino N; Uchiyama K; Mabuchi T; Sakata K; Kaneda T; Fujita T; Masuta E; Mabuchi H
    Clin Sci (Lond); 2006 Jan; 110(1):125-31. PubMed ID: 16181148
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Different Phenotypes of Anderson-Fabry Disease Identified with Cardiac Magnetic Resonance Imaging in a Family with the Same Late-Onset Mutation.
    Ávila-Sánchez DA; Cambronero-Cortinas E; Barreiro-Pérez M; Rodríguez-Hernández JL; Díaz-Fernández B; Sánchez PL
    Am J Case Rep; 2020 Oct; 21():e925631. PubMed ID: 33119553
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevalence of Fabry disease in female patients with late-onset hypertrophic cardiomyopathy.
    Chimenti C; Pieroni M; Morgante E; Antuzzi D; Russo A; Russo MA; Maseri A; Frustaci A
    Circulation; 2004 Aug; 110(9):1047-53. PubMed ID: 15313943
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Association between polymorphisms of endothelial nitric oxide synthase gene (NOS3) and left posterior wall thickness (LPWT) of the heart in Fabry disease.
    Rohard I; Schaefer E; Kampmann C; Beck M; Gal A
    J Inherit Metab Dis; 2008 Dec; 31 Suppl 2():S349-56. PubMed ID: 18941922
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fabry Disease and/or Hypertrophic Cardiomyopathy.
    Anan R
    Int Heart J; 2017 May; 58(3):305-306. PubMed ID: 28539575
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparative analysis of right ventricular strain in Fabry cardiomyopathy and sarcomeric hypertrophic cardiomyopathy.
    Meucci MC; Lillo R; Lombardo A; Lanza GA; Bootsma M; Butcher SC; Massetti M; Manna R; Bax JJ; Crea F; Ajmone Marsan N; Graziani F
    Eur Heart J Cardiovasc Imaging; 2023 Mar; 24(4):542-551. PubMed ID: 35900225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic polymorphisms in the renin-angiotensin-aldosterone system associated with expression of left ventricular hypertrophy in hypertrophic cardiomyopathy: a study of five polymorphic genes in a family with a disease causing mutation in the myosin binding protein C gene.
    Ortlepp JR; Vosberg HP; Reith S; Ohme F; Mahon NG; Schröder D; Klues HG; Hanrath P; McKenna WJ
    Heart; 2002 Mar; 87(3):270-5. PubMed ID: 11847170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Atypical patterns of cardiac involvement in Fabry disease.
    Coughlan JJ; Elkholy K; O'Brien J; Kiernan T
    BMJ Case Rep; 2016 Mar; 2016():. PubMed ID: 26989114
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Right ventricular myocardial diastolic dysfunction in different kinds of cardiac hypertrophy: analysis by pulsed Doppler tissue imaging.
    Galderisi M; Severino S; Caso P; Cicala S; Petrocelli A; De Simone L; Mininni N; de Divitiis O
    Ital Heart J; 2001 Dec; 2(12):912-20. PubMed ID: 11838339
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genetic variation in angiotensin II type 2 receptor gene influences extent of left ventricular hypertrophy in hypertrophic cardiomyopathy independent of blood pressure.
    Carstens N; van der Merwe L; Revera M; Heradien M; Goosen A; Brink PA; Moolman-Smook JC
    J Renin Angiotensin Aldosterone Syst; 2011 Sep; 12(3):274-80. PubMed ID: 21163866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hypertrophic cardiomyopathy in late-onset variant of Fabry disease with high residual activity of alpha-galactosidase A.
    Nagao Y; Nakashima H; Fukuhara Y; Shimmoto M; Oshima A; Ikari Y; Mori Y; Sakuraba H; Suzuki Y
    Clin Genet; 1991 Mar; 39(3):233-7. PubMed ID: 1645238
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence and clinical features of Fabry disease in Japanese male patients with diagnosis of hypertrophic cardiomyopathy.
    Kubo T; Ochi Y; Baba Y; Hirota T; Tanioka K; Yamasaki N; Yoshimitsu M; Higuchi K; Takenaka T; Nakajima K; Togawa T; Tsukimura T; Sano S; Tei C; Sakuraba H; Kitaoka H
    J Cardiol; 2017 Jan; 69(1):302-307. PubMed ID: 27554049
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Long Term Follow-up Study of Carriers of Hypertrophic Cardiomyopathy Mutations.
    McTaggart DR; Ogden KJ; Marathe JA
    Heart Lung Circ; 2017 Jan; 26(1):18-24. PubMed ID: 27373729
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Left atrial enlargement and reduced atrial compliance occurs early in Fabry cardiomyopathy.
    Boyd AC; Lo Q; Devine K; Tchan MC; Sillence DO; Sadick N; Richards DA; Thomas L
    J Am Soc Echocardiogr; 2013 Dec; 26(12):1415-23. PubMed ID: 24094560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypertrophic cardiomyopathy and left ventricular hypertrophy in hypertensive heart disease with mildly reduced or preserved ejection fraction: insight from altered mechanics and native T1 mapping.
    Wu LM; An DL; Yao QY; Ou YZ; Lu Q; Jiang M; Xu JR
    Clin Radiol; 2017 Oct; 72(10):835-843. PubMed ID: 28552325
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.